Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up

Affiliations

• ¹ Department of Dermatology-Venereology, Andreas Sygros Hospital-National and Kapodistrian University of Athens, Athens, Greece. Electronic address: alstrat2@gmail.com.
• ² Department of Dermatology, Arizona Mayo Clinic, Scottsdale, Arizona.
• ³ Dipartimento di Scienze Mediche e Chirurgiche, UOC di Dermatologia, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy.
• ⁴ Department of General Medical Oncology, University Hospitals, Leuven, Belgium.
• ⁵ Department of Dermatology, Bordeaux University Hospital, Bordeaux, France.
• ⁶ School of Medicine, University of Colorado, Aurora, Colorado.
• ⁷ Department of Dermatology, Hôpital Saint-Louis, Paris, France.
• ⁸ Department of Dermatology, Stanford University School of Medicine, Stanford, California.
• ⁹ Department of Dermatology, Centre Hospitalier Lyon-Sud, Lyon, France.
• ¹⁰ Department of Dermatology, Hospital Universitario Virgen Macarena, Seville, Spain.
• ¹¹ Medical Oncology Head and Neck Cancer Department, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy.
• ¹² Dermatology Unit, Gustave Roussy Cancer Center and Paris-Saclay University, Villejuif, France.
• ¹³ Skin Cancer Centre, Charite-Universitätsmedizin Berlin, Berlin, Germany.
• ¹⁴ Department of Dermatology, University of Kiel, Kiel, Germany.
• ¹⁵ Departments of Dermatology and Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
• ¹⁶ Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
• ¹⁷ Regeneron Pharmaceuticals, Inc, Tarrytown, New York.
• ¹⁸ Faculty of Medicine, Department of Skin and Venereal Diseases, School of Health Sciences, University of Ioannina, Ioannina, Greece.
• ¹⁹ Department of Dermatology, University Medical Center Mainz, Mainz, Germany.
• ²⁰ Departments of Dermatology, Human Pathology, and Oncology, University of Florence, Florence, Italy.
• ²¹ Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida.
• ²² Johannes Wesling Medical Center, Ruhr University Bochum, Minden, Germany.
• ²³ Academic Teaching Hospital of the University Otto von Guericke Magdeburg, Quedlinburg, Germany.
• ²⁴ Dermatology Department, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
• ²⁵ Sanofi, Cambridge, Massachusetts.